Clinical Trials

Study Title:
AHOD2131 - A Randomized, Phase 3 Interim Response Adapted Trial Comparing Standard Therapy with Immuno-oncology Therapy for Children and Adults with Newly Diagnosed Stage I and Stage II Classic Hodgkin Lymphoma

For more information about the trial above please contact the study team: Medical University of South Carolina Principal Investigator, Jacqueline Kraveka, at kravekjm@musc.edu. Study Coordinator, Hannah Kinder, at kinderh@musc.edu. Trial opened at the following institutions: Medical University of South Carolina